Description

Lenvatinib 4mg Overview

Lenvatinib is a tyrosine kinase inhibitor used in the treatment of various cancers. The 4mg capsule is one of the dosage forms available for this medication.

Uses

• Thyroid Cancer: Lenvatinib is used to treat differentiated thyroid cancer (DTC) that is progressive, locally advanced, or metastatic and refractory to radioactive iodine (RAI) therapy27.

• Liver Cancer: It is also used for the treatment of advanced or unresectable hepatocellular carcinoma (HCC) in patients who have not received prior systemic therapy26.

• Renal Cell Carcinoma and Endometrial Cancer: Lenvatinib is used in combination with other drugs for these conditions5.

Dosage

The recommended daily dose of lenvatinib varies based on the condition being treated and the patient’s body weight:

• For DTC and HCC, the dose is typically 8 mg (two 4 mg capsules) for patients weighing less than 60 kg and 12 mg (three 4 mg capsules) for those weighing 60 kg or more2.

• For endometrial cancer, the dose may involve a combination of different capsule strengths